Federal Register / Vol. 71, No.
97 / Friday, May 19, 2006 / Notices
Questionnaire for conference registrants/attendees ...................................................................
Focus groups ...............................................................................................................................
Web-based ...................................................................................................................................
Other customer surveys ..............................................................................................................
Dated: May 9, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–7634 Filed 5–18–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Cost &
Effectiveness of Pertussis Vaccination
Among Healthcare Workers, Request
for Applications (RFA) IP 06–001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel (SEP): Cost & Effectiveness of Pertussis
Vaccination Among Healthcare Workers,
RFA IP 06–001.
Time and Date: 12 p.m.–4 p.m., June 26,
2006 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Cost & Effectiveness of Pertussis
Vaccination Among Healthcare Workers,’’
RFA IP 06–001.
For Further Information Contact: Christine
Morrison, Ph.D., Scientific Review
Administrator, Office of Extramural
Research, CDC, 1600 Clifton Road, NE.,
Mailstop D72, Atlanta, GA 30333, Telephone
(404) 639–3098.
The Director, Management Analysis and
wwhite on PROD1PC61 with NOTICES
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
VerDate Aug<31>2005 17:37 May 18, 2006
29155
ESTIMATED ANNUALIZED BURDEN HOURS
Type of survey
Dated: May 11, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–7631 Filed 5–18–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Industrial
Costs of Developing and
Commercializing Childhood Vaccines,
Request for Applications (RFA) IP 06–
010
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel (SEP): Industrial Costs of Developing
and Commercializing Childhood Vaccines,
RFA IP 06–010.
Time and Date: 12 p.m.–4 p.m., June 29,
2006 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Industrial Costs of Developing
and Commercializing Childhood Vaccines,’’
RFA IP 06–010.
For Further Information Contact: Christine
Morrison, Ph.D., Scientific Review
Administrator, Office of Extramural
Research, CDC, 1600 Clifton Road NE,
Mailstop D72, Atlanta, GA 30333, Telephone
(404) 639–3098.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
Jkt 208001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703
Average
Number of
Number of burden per
responses per
respondents response
respondent (in hours)
1,000 1 10/60
80 1 1
1,200 1 10/60
400 1 15/60
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: May 11, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–7635 Filed 5–18–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry
The Program Peer Review
Subcommittee of the Board of Scientific
Counselors (BSC), Centers for Disease
Control and Prevention (CDC), National
Center for Environmental Health/
Agency for Toxic Substances and
Disease Registry (NCEH/ATSDR):
Teleconference.
In accordance with section 10(d) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC, NCEH/ATSCR
announces the following subcommittee
meeting:
Name: Program Peer Review Subcommittee
(PPRS).
Time and Date: 10 a.m—12 p.m. eastern
daylight time, June 8, 2006.
Place: The teleconference will originate at
NCEH/ATSDR in Atlanta, Georgia. To
participate, dial 877/315–6535 and enter
conference code 383520.
Purpose: Under the charge of the BSC,
NCEH/ATSDR, the PPRS will provide the
BSC, NCEH/ATSDR with advice and
recommendations on NCEH/ATSDR program
peer review. They will serve the function of
organizing, facilitating, and providing a long-
term perspective to the conduct of NCEH/
ATSDR program peer review.
Matters to be Discussed: A discussion of
the Intramural Program Peer Review Process.
Agenda items are subject to change as
priorities dictate.
Supplementary Information: The public
comment period is from 11:45—11:55 a.m.
Contact Person for More Information:
Sandra Malcolm, Committee Management
Specialist, Office of Science, NCEH/ATSDR,
E:\FR\FM\19MYN1.SGM 19MYN1